Satellos Bioscience (TSX:MSCL) Treasury Stock : C$0.00 Mil (As of Dec. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Satellos Bioscience Treasury Stock?

Treasury stock is the portion of shares that a company keeps in their own treasury. Satellos Bioscience's treasury stock for the quarter that ended in Dec. 2024 was C$0.00 Mil.

Treasury stock may have come from a repurchase or buyback from shareholders; or it may have never been issued to the public in the first place.

Satellos Bioscience Treasury Stock Historical Data

The historical data trend for Satellos Bioscience's Treasury Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Satellos Bioscience Treasury Stock Chart

Satellos Bioscience Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Dec24

Treasury Stock

Satellos Bioscience Quarterly Data
	Jun20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Treasury Stock	Get a 7-Day Free Trial													-	-	-	-	-

Satellos Bioscience Treasury Stock Calculation

The portion of shares that a company keeps in their own treasury. Treasury stock may have come from a repurchase or buyback from shareholders; or it may have never been issued to the public in the first place. These shares don't pay dividends, have no voting rights, and should not be included in shares outstanding calculations.

Satellos Bioscience Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Satellos Bioscience Inc (TSX:MSCL) » Definitions » Treasury Stock

Comparable Companies

Traded in Other Exchanges

MSCLF:USA 0ITA:Germany

Address

200 Bay Street, Suite 2800, Royal Bank Plaza, South Tower, Toronto, ON, CAN, M5J 2J1

Website

https://www.satellos.com

Satellos Bioscience Inc is a regenerative medicine company a biotechnology and drug development company. The company is developing novel therapeutics that stimulate or restore muscle regeneration in severe disorders. The company's program is focused on developing an oral therapeutic drug for Duchenne muscular dystrophy that serves to correct this dysregulation which Satellos has identified as a root cause of the progressive nature of this disease.

Satellos Bioscience Headlines

No Headlines